Evidence map›Paper›PMID 24379397›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Structural insights into gene repression by the orphan nuclear receptor SHP.

Xiaoyong Zhi, X Edward Zhou, Yuanzheng He, Christoph Zechner, Kelly M Suino-Powell, Steven A Kliewer, Karsten Melcher, David J Mangelsdorf, H Eric Xu

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. The nuclear receptor superfamily: A structural perspective.Protein science : a publication of the Protein Society · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Crystal structures of MBP fusion proteins.Protein science : a publication of the Protein Society · 2016
    Review
  14. Article
  15. Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?Annual review of pharmacology and toxicology · 2016
    Review
  16. Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Xiaoyong ZhiLaboratory of Structural Sciences, Van Andel Research Institute, Grand Rapids, MI 49503.
X Edward Zhou
Yuanzheng He
Christoph Zechner
Kelly M Suino-Powell
Steven A Kliewer
Karsten Melcher
David J Mangelsdorf
H Eric Xu
Van Andel Institute · USSouthwestern Medical Center · US

Funding

ENDOCRINE &METABOLISM TRAINING GRANTT32DK007307 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI PHILIPP E SCHERER · 1986 to 2026
$5.4M
Structural Genomics of Orphan Nuclear ReceptorsR01DK071662 · NIDDK · VAN ANDEL RESEARCH INSTITUTE · PI XU, H ERIC · 2005 to 2017
$5.1M
Tissue-specific Mechanism of Action of the Metabolic Hormones FGF19 and FGF21R01DK067158 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI KLIEWER, STEVEN A. · 2004 to 2017
$4.1M
Howard Hughes Medical InstituteNIDDK NIH HHS R01 DK067158NIDDK NIH HHS R01 DK071662NIDDK NIH HHS T32 DK007307
6 · The paper itself

Abstract

Small heterodimer partner (SHP) is an orphan nuclear receptor that functions as a transcriptional repressor to regulate bile acid and cholesterol homeostasis. Although the precise mechanism whereby SHP represses transcription is not known, E1A-like inhibitor of differentiation (EID1) was isolated as a SHP-interacting protein and implicated in SHP repression. Here we present the crystal structure of SHP in complex with EID1, which reveals an unexpected EID1-binding site on SHP. Unlike the classical cofactor-binding site near the C-terminal helix H12, the EID1-binding site is located at the N terminus of the receptor, where EID1 mimics helix H1 of the nuclear receptor ligand-binding domain. The residues composing the SHP-EID1 interface are highly conserved. Their mutation diminishes SHP-EID1 interactions and affects SHP repressor activity. Together, these results provide important structural insights into SHP cofactor recruitment and repressor function and reveal a conserved protein interface that is likely to have broad implications for transcriptional repression by orphan nuclear receptors.

Indexed as

Models, MolecularProtein ConformationBile Acids and SaltsBinding SitesCell Cycle ProteinsCell LineCholesterolCrystallizationDrug DesignHomeostasisHumansNuclear ProteinsReceptors, Cytoplasmic and NuclearRepressor ProteinsBile Acids and SaltsCell Cycle ProteinsCholesterolEID1 protein, humanNuclear Proteinsnuclear receptor subfamily 0, group B, member 2Receptors, Cytoplasmic and NuclearRepressor Proteins

Identifiers

PMID24379397
PMCPMC3896210
OpenAlexW1983412315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.